Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L H Lam

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 28, 2020
Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal InsufficiencyAnnaswamy Raji, Zhi Jin Xu, Raymond L H Lam, et al.
Dementia and Geriatric Cognitive Disorders Extra|February 17, 2017
Generalization of Context-Specific Training in Individuals with Mild Cognitive Impairment: An Event-Related Potential StudySam C C Chan, Tommy L H Lam, Kenneth N K Fong, et al.
Diabetes, Obesity & Metabolism|July 19, 2018
A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT-R studyRussell Scott, Jerry Morgan, Zachary Zimmer, et al.
The Journal of Biological Chemistry|March 5, 1993
Structure and biological activities of a heparin-derived hexasaccharide with high affinity for basic fibroblast growth factorD J Tyrrell, M Ishihara, N Rao, et al.
Journal of Hepatology|June 24, 2023
A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver diseaseManuel Romero-Gómez, Eric Lawitz, R Ravi Shankar, et al.
Human & Experimental Toxicology|November 9, 2010
Permanent deficits in brain functions caused by long-term ketamine treatment in miceL Sun, W P Lam, Y W Wong, et al.
Emerging Infectious Diseases|October 2, 2008
Effects of school closures, 2008 winter influenza season, Hong KongBenjamin J Cowling, Eric H Y Lau, Conrad L H Lam, et al.
Microscopy Research and Technique|May 15, 2012
Extract of white button mushroom affects skin healing and angiogenesisW P Lam, C M Wang, T Y Tsui, et al.
Diabetes, Obesity & Metabolism|May 17, 2018
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trialPhilip D Home, Raymond L H Lam, Wendy L Carofano, et al.
Diabetes, Obesity & Metabolism|January 5, 2019
Double-blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT-M studyJuan P Frias, Zachary Zimmer, Raymond L H Lam, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 28, 2020
Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal InsufficiencyAnnaswamy Raji, Zhi Jin Xu, Raymond L H Lam, et al.
Dementia and Geriatric Cognitive Disorders Extra|February 17, 2017
Generalization of Context-Specific Training in Individuals with Mild Cognitive Impairment: An Event-Related Potential StudySam C C Chan, Tommy L H Lam, Kenneth N K Fong, et al.
Diabetes, Obesity & Metabolism|July 19, 2018
A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT-R studyRussell Scott, Jerry Morgan, Zachary Zimmer, et al.
The Journal of Biological Chemistry|March 5, 1993
Structure and biological activities of a heparin-derived hexasaccharide with high affinity for basic fibroblast growth factorD J Tyrrell, M Ishihara, N Rao, et al.
Journal of Hepatology|June 24, 2023
A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver diseaseManuel Romero-Gómez, Eric Lawitz, R Ravi Shankar, et al.
Human & Experimental Toxicology|November 9, 2010
Permanent deficits in brain functions caused by long-term ketamine treatment in miceL Sun, W P Lam, Y W Wong, et al.
Emerging Infectious Diseases|October 2, 2008
Effects of school closures, 2008 winter influenza season, Hong KongBenjamin J Cowling, Eric H Y Lau, Conrad L H Lam, et al.
Microscopy Research and Technique|May 15, 2012
Extract of white button mushroom affects skin healing and angiogenesisW P Lam, C M Wang, T Y Tsui, et al.
Diabetes, Obesity & Metabolism|May 17, 2018
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trialPhilip D Home, Raymond L H Lam, Wendy L Carofano, et al.
Diabetes, Obesity & Metabolism|January 5, 2019
Double-blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT-M studyJuan P Frias, Zachary Zimmer, Raymond L H Lam, et al.
Pageof 3